Effects of IL-1β, TNF-α and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells

Respirology

Volumn 8, Issue 4, 2003, Pages 467-472

  Itoh, Akihide ^a,d   Nishihira, Jun ^b   Makita, Hironi ^a   Miyamoto, Kenji ^c   Yamaguchi, Etsuro ^a   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b Central Research Institute   (Japan)

^c Hokkaido University   (Japan)

^d Hokkaido Social Insurance Hospital   (Japan)

Author keywords

Interleukin 1; Macrophage migration inhibitory factor; Prostaglandins; Pulmonary artery; Tumour necrosis factor

Indexed keywords

ARACHIDIC ACID; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; PROSTACYCLIN; PROSTACYCLIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; 6 OXOPROSTAGLANDIN F1 ALPHA; CYTOCHROME P450; INTERLEUKIN 1; ISOENZYME; ISOMERASE; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; LUNG ARTERY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE FIBER; ANALYSIS OF VARIANCE; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; METABOLISM; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

6-KETOPROSTAGLANDIN F1 ALPHA; ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOCHROME P-450 ENZYME SYSTEM; EPOPROSTENOL; INTERLEUKIN-1; INTRAMOLECULAR OXIDOREDUCTASES; ISOENZYMES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0348148820     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1843.2003.00491.x     Document Type: Article

References (30)

1. Veyssier-Belot C, Cacoub P. Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension. Cardiovasc. Res. 1999; 44: 274-82.
2. Voelkel NF, Tuder RM, Bridges J, Arend WP. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am. J. Respir. Cell Mol. Biol. 1994; 11: 664-75.
3. Humbert M, Monti G, Brenot F et al. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 1995; 151: 1628-31.
4. Lesprit P, Godeau B, Authier FJ et al. Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines. Am. J. Respir. Crit. Care Med. 1998; 157: 907-11.
5. Geraci MW, Gao B, Shepherd DC et al. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J. Clin. Invest. 1999; 103: 1509-15.
6. Christman BW, McPherson CD, Newman JH et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 1992; 327: 70-5.
7. Tuder RM, Cool CD, Geraci MW et al. Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension. Am. J. Respir. Crit. Care Med. 1999; 159: 1925-32.
8. Barst RJ, Rubin LJ, Long WA et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N. Engl. J. Med. 1996; 334: 296-302.
9. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 1993; 268: 9049-54.
10. 2 by cultured human pulmonary artery smooth muscle cells. Prostaglandins Leukot. Essent. Fatty Acids 1997; 56: 185-92.
11. Wen FQ, Watanabe K, Yoshida M. Eicosanoid profile in cultured human pulmonary artery smooth muscle cells treated with IL-1 beta and TNF alpha. Prostaglandins Leukot. Essent. Fatty Acids 1998; 59: 71-5.
12. Nishihira J. Novel pathophysiological aspects of macrophage migration inhibitory factor (review). Int. J. Mol. Med. 1998; 2: 17-28.
13. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc. Natl Acad. Sci. USA 1995; 92: 1475-9.
14. Nishihira J, Kuriyama T, Sakai M, Nishi S, Ohki S, Hikichi K. The structure and physicochemical properties of rat liver macrophage migration inhibitory factor. Biochim. Biophys. Acta 1995; 1247: 159-62.
15. 2. Annu. Rev. Pharmacol. Toxicol. 1999; 39: 175-89.
16. Ausubel FM, Brent R, Kingston RE et al. Current Protocols in Molecular Biology on CD-ROM. Wiley, New York, 1998.
17. FitzGerald GA, Pedersen AK, Patrono C. Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease. Circulation 1983; 67: 1174-7.
18. 2 and prostacyclin production by proliferating rat smooth muscle cells. Prostaglandins 1993; 46: 331-46.
19. Hara S, Morishita R, Tone Y et al. Overexpression of prostacyclin synthase inhibits growth of vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 1995; 216: 862-7.
20. Hirst SJ, Barnes PJ, Twort CH. Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. Am. J. Respir. Cell Mol. Biol. 1992; 7: 574-81.
21. Belton O, Byrne D, Kearney D, Leahy A, Fitzgerald DJ. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 2000; 102: 840-5.
22. Godfrey RW, Johnson WJ, Hoffstein ST. Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism. Biochem. Biophys. Res. Commun. 1987; 142: 235-41.
23. 2 in mixed incubations of endothelial cells and aspirin-treated patelets strongly depends on the prostaglandin I-synthase activity. Thromb. Res. 2000; 99: 155-64.
24. Pasricha PJ, Hassoun PM, Teufel E, Landman MJ, Fanburg BL. Prostaglandins E1 and E2 stimulate the proliferation of pulmonary artery smooth muscle cells. Prostaglandins 1992; 43: 5-19.
25. 2 synthase antigen in smooth muscle cells. J. Biol. Chem. 1983; 258: 5922-6.
26. Tone Y, Inoue H, Hara S et al. The regional distribution and cellular localization of mRNA encoding rat prostacyclin synthase. Eur. J. Cell Biol. 1997; 72: 268-77.
27. Fujita M, Shannon JM, Irvin CG et al. Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001; 280: L39-49.
28. 2 by cultured human pulmonary artery smooth muscle cells. Prostaglandins 1996; 52: 93-102.
29. Humbert M, Trembath RC. Genetics of pulmonary hypertension: from bench to bedside. Eur. Respir. J. 2002; 20: 741-9.
30. Du L, Sullivan CC, Chu D et al. Signaling molecules in nonfamilial pulmonary hypertension. N. Engl. J. Med. 2003; 348: 500-9.